BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11/08/2009

Regulatory Committee to Review Use of Ozone-Depleting Substances in Epinephrine Products

The Environmental Protection Agency (EPA) has announced a review of the use of ozone-depleting substances in epinephrine products, following a request from the American Medical Association (AMA) to assess the safety of these substances.

Source: Federal Register — Food and Drug AdministrationOpen original release →